Cargando…
Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
OBJECTIVE: The strong association between psychiatric patients who receive antipsychotics and the incidence of venous thromboembolism (VTE) is known. Although previous reports suggest that hyperprolactinemia often increases markers of activated coagulation, few studies have examined the direct relat...
Autores principales: | Ishioka, Masamichi, Yasui-Furukori, Norio, Sugawara, Norio, Furukori, Hanako, Kudo, Shuhei, Nakamura, Kazuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348124/ https://www.ncbi.nlm.nih.gov/pubmed/25750528 http://dx.doi.org/10.2147/NDT.S75176 |
Ejemplares similares
-
The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study
por: Hashimoto, Kojiro, et al.
Publicado: (2014) -
Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2019) -
PM399. Attitudes toward antipsychotic long-acting injections among patients with Schizophrenia in Japan.
por: Kudo, Shuhei, et al.
Publicado: (2016) -
Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2015) -
The low level of understanding of depression among patients treated with antidepressants: a survey of 424 outpatients in Japan
por: Kudo, Shuhei, et al.
Publicado: (2015)